These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17464087)

  • 1. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial.
    Yoon SH; Shim YS; Park YH; Chung JK; Nam JH; Kim MO; Park HC; Park SR; Min BH; Kim EY; Choi BH; Park H; Ha Y
    Stem Cells; 2007 Aug; 25(8):2066-73. PubMed ID: 17464087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor.
    Park HC; Shim YS; Ha Y; Yoon SH; Park SR; Choi BH; Park HS
    Tissue Eng; 2005; 11(5-6):913-22. PubMed ID: 15998231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients.
    El-Kheir WA; Gabr H; Awad MR; Ghannam O; Barakat Y; Farghali HA; El Maadawi ZM; Ewes I; Sabaawy HE
    Cell Transplant; 2014 Apr; 23(6):729-45. PubMed ID: 23452836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.
    Syková E; Jendelová P; Urdzíková L; Lesný P; Hejcl A
    Cell Mol Neurobiol; 2006; 26(7-8):1113-29. PubMed ID: 16633897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study.
    Saito F; Nakatani T; Iwase M; Maeda Y; Murao Y; Suzuki Y; Fukushima M; Ide C
    Restor Neurol Neurosci; 2012; 30(2):127-36. PubMed ID: 22232031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients.
    Karamouzian S; Nematollahi-Mahani SN; Nakhaee N; Eskandary H
    Clin Neurol Neurosurg; 2012 Sep; 114(7):935-9. PubMed ID: 22464434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study.
    Chhabra HS; Sarda K; Arora M; Sharawat R; Singh V; Nanda A; Sangodimath GM; Tandon V
    Spinal Cord; 2016 Jan; 54(1):57-64. PubMed ID: 26282492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury.
    Dai G; Liu X; Zhang Z; Yang Z; Dai Y; Xu R
    Brain Res; 2013 Oct; 1533():73-9. PubMed ID: 23948102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report.
    Chotivichit A; Ruangchainikom M; Chiewvit P; Wongkajornsilp A; Sujirattanawimol K
    J Med Case Rep; 2015 Apr; 9():79. PubMed ID: 25885347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
    Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
    Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
    Nemunaitis J; Rabinowe SN; Singer JW; Bierman PJ; Vose JM; Freedman AS; Onetto N; Gillis S; Oette D; Gold M
    N Engl J Med; 1991 Jun; 324(25):1773-8. PubMed ID: 1903847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats.
    Urdzíková L; Jendelová P; Glogarová K; Burian M; Hájek M; Syková E
    J Neurotrauma; 2006 Sep; 23(9):1379-91. PubMed ID: 16958589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
    Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
    Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
    Klingemann HG; Wilkie-Boyd K; Rubin A; Onetto N; Nantel SH; Barnett MJ; Reece DE; Shepherd JD; Phillips GL
    Biotechnol Ther; 1994; 5(1-2):1-13. PubMed ID: 7703829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
    Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
    Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.